Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Intangibles (2016 - 2021)

Historic Intangibles for Assembly Biosciences (ASMB) over the last 7 years, with Q3 2021 value amounting to $29.0 million.

  • Assembly Biosciences' Intangibles changed 0.0% to $29.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $29.0 million for FY2020, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2021, Assembly Biosciences' Intangibles is $29.0 million, which was down 0.0% from $29.0 million recorded in Q2 2021.
  • Assembly Biosciences' Intangibles' 5-year high stood at $29.0 million during Q1 2017, with a 5-year trough of $29.0 million in Q1 2017.
  • In the last 5 years, Assembly Biosciences' Intangibles had a median value of $29.0 million in 2017 and averaged $29.0 million.
  • Data for Assembly Biosciences' Intangibles shows a peak YoY increase of 0.0% (in 2017) and a maximum YoY decrease of 0.0% (in 2017) over the last 5 years.
  • Assembly Biosciences' Intangibles (Quarter) stood at $29.0 million in 2017, then changed by 0.0% to $29.0 million in 2018, then changed by 0.0% to $29.0 million in 2019, then changed by 0.0% to $29.0 million in 2020, then changed by 0.0% to $29.0 million in 2021.
  • Its last three reported values are $29.0 million in Q3 2021, $29.0 million for Q2 2021, and $29.0 million during Q1 2021.